Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florentia Dimitriou

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV|April 25, 2026
Redefining skin toxicity in the age of precision immunotherapyFlorentia Dimitriou, Christian Posch
Acta Dermato-Venereologica|October 19, 2019
Hair Depigmentation and Hair Loss in Advanced Melanoma Treated with Combined Immunotherapy and Targeted TherapyFlorentia Dimitriou, Joanna Mangana, Reinhard Dummer
Current Opinion in Oncology|December 20, 2017
Update on adjuvant melanoma therapyFlorentia Dimitriou, Ralph Peter Braun, Joanna Mangana
Hematology/Oncology Clinics of North America|May 23, 2024
Skin Cancer Precursors: From Cancer Genomics to Early DiagnosisMadison M Taylor, Kelly C Nelson, Florentia Dimitriou
Cancers|November 26, 2022
Triple Combination of Immune Checkpoint Inhibitors and BRAF/MEK Inhibitors in <i>BRAF</i>V600 Melanoma: Current Status and Future PerspectivesMichèle Welti, Florentia Dimitriou, Ralf Gutzmer, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 6, 2022
Double Trouble: Immunotherapy Doublets in Melanoma-Approved and Novel Combinations to Optimize Treatment in Advanced MelanomaFlorentia Dimitriou, Axel Hauschild, Janice M Mehnert, et al.
Melanoma Research|December 18, 2018
Cytokine release syndrome as an important differential diagnosis of severe skin toxicity with organ damage during switch from immunotherapy to targeted therapy in metastatic melanomaFlorentia Dimitriou, Joanna Mangana, Sara Micaletto, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2021
Interleukin-6 blockade for prophylaxis and management of immune-related adverse events in cancer immunotherapyFlorentia Dimitriou, Sabrina Hogan, Alexander M Menzies, et al.
Clinical Nuclear Medicine|April 5, 2023
Internal Thoracic Vein Tumor Thrombus From Sternal Melanoma Metastasis on 18 F-FDG PET/CTFalko Ensle, Jan A Schaab, Florentia Dimitriou, et al.
International Archives of Allergy and Immunology|July 22, 2020
Pathogenesis and Therapy of Primary Cutaneous T-Cell Lymphoma: Collegium Internationale Allergologicum (CIA) Update 2020Malgorzata Bobrowicz, Christina Fassnacht, Desislava Ignatova, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Journal of the European Academy of Dermatology and Venereology : JEADV|April 25, 2026
Redefining skin toxicity in the age of precision immunotherapyFlorentia Dimitriou, Christian Posch
Acta Dermato-Venereologica|October 19, 2019
Hair Depigmentation and Hair Loss in Advanced Melanoma Treated with Combined Immunotherapy and Targeted TherapyFlorentia Dimitriou, Joanna Mangana, Reinhard Dummer
Current Opinion in Oncology|December 20, 2017
Update on adjuvant melanoma therapyFlorentia Dimitriou, Ralph Peter Braun, Joanna Mangana
Hematology/Oncology Clinics of North America|May 23, 2024
Skin Cancer Precursors: From Cancer Genomics to Early DiagnosisMadison M Taylor, Kelly C Nelson, Florentia Dimitriou
Cancers|November 26, 2022
Triple Combination of Immune Checkpoint Inhibitors and BRAF/MEK Inhibitors in <i>BRAF</i>V600 Melanoma: Current Status and Future PerspectivesMichèle Welti, Florentia Dimitriou, Ralf Gutzmer, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 6, 2022
Double Trouble: Immunotherapy Doublets in Melanoma-Approved and Novel Combinations to Optimize Treatment in Advanced MelanomaFlorentia Dimitriou, Axel Hauschild, Janice M Mehnert, et al.
Melanoma Research|December 18, 2018
Cytokine release syndrome as an important differential diagnosis of severe skin toxicity with organ damage during switch from immunotherapy to targeted therapy in metastatic melanomaFlorentia Dimitriou, Joanna Mangana, Sara Micaletto, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2021
Interleukin-6 blockade for prophylaxis and management of immune-related adverse events in cancer immunotherapyFlorentia Dimitriou, Sabrina Hogan, Alexander M Menzies, et al.
Clinical Nuclear Medicine|April 5, 2023
Internal Thoracic Vein Tumor Thrombus From Sternal Melanoma Metastasis on 18 F-FDG PET/CTFalko Ensle, Jan A Schaab, Florentia Dimitriou, et al.
International Archives of Allergy and Immunology|July 22, 2020
Pathogenesis and Therapy of Primary Cutaneous T-Cell Lymphoma: Collegium Internationale Allergologicum (CIA) Update 2020Malgorzata Bobrowicz, Christina Fassnacht, Desislava Ignatova, et al.
Pageof 6